Literature DB >> 7189685

Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.

C J Carter, C J Pycock.   

Abstract

The effects of 6-hydroxydopamine (6-OHDA) lesions of catecholamine terminals within the medial prefrontal cortex on spontaneous motor activity, dopamine (DA)-dependent stereotyped behaviour and subcortical dopamine turnover were investigated in the rat. Two types of lesions were examined, bilateral injection of 6-OHDA into the medial prefrontal cortex of untreated rats (6-OHDA alone), and bilateral injection of 6-OHDA into the medial prefrontal cortex of animals pretreated with the noradrenaline (NA) uptake blocking agent desmethylimipramine (6-OHDA/-DMI). Ten days after surgery the 6-OHDA lesions produced no significant change in spontaneous motor activity and had no overall effects on stereotyped behaviour induced by apomorphine or (+)-amphetamine. This lesion caused gross depletion of NA within the medial prefrontal cortex and curiously, elevated DA concentrations within this site. No changes in DA concentration were recorded within subcortical sites, although concentrations of DA metabolites within striatum and nucleus accumbens were reduced. In contrast, the 6-OHDA/DMI lesion of the medial prefrontal cortex significantly enhanced spontaneous motor activity and amphetamine-induced stereotyped behaviour. Apomorphine-induced stereotypy, on the other hand, was significantly reduced. Biochemically the lesion caused a large depletion of DA with relatively little loss of NA within the medial prefrontal cortex. In addition, from this and another study (ref. 33), increases in DA and its metabolite concentrations were measured in striatum and nucleus accumbens, together with an apparent increase in DA turnover within these subcortical sites. It is thus apparent that in the absence of a substantial portion of the DA innervation of the medial prefrontal cortex, with a largely intact NA innervation, there is an increase in motor activity and amphetamine-induced stereotypy which may be related to functional changes in DA activity within subcortical telencephalic structures. Such a finding might suggest that DA within the frontal cortex has a behaviourally inhibitory role in the rat, although further work is required to substantiate this.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189685     DOI: 10.1016/0006-8993(80)91016-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.

Authors:  Osnat Ben-Shahar; Patrick Keeley; Mariana Cook; Wayne Brake; Megan Joyce; Myriel Nyffeler; Rebecca Heston; Aaron Ettenberg
Journal:  Brain Res       Date:  2006-12-11       Impact factor: 3.252

2.  The syndrome of motor restlessness--a treatable but under-recognised disorder.

Authors:  A Bakheit
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

3.  Ontogeny of PFC-related behaviours is sensitive to a single non-invasive dose of methamphetamine in neonatal gerbils (Meriones unguiculatus).

Authors:  R R Dawirs; G Teuchert-Noodt; R Czaniera
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine.

Authors:  M T Martin-Iverson; C Szostak; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Akathisia following traumatic brain injury: treatment with bromocriptine.

Authors:  J T Stewart
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-10       Impact factor: 10.154

Review 6.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.

Authors:  B A Shaywitz; M H Teicher; D J Cohen; G M Anderson; J G Young; P Levitt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.

Authors:  J Arnt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

9.  Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.

Authors:  S J Wanchoo; M J Lee; A C Swann; N Dafny
Journal:  Brain Res       Date:  2009-11-22       Impact factor: 3.252

10.  Further contribution to the study of corticostriatal glutamatergic and nigrostriatal dopaminergic interactions within the striatal network: an in vivo voltammetric investigation.

Authors:  C Forni; N Dusticier; A Nieoullon
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.